Outcomes of front ‐line ibrutinib treated CLL patients excluded from landmark clinical trial
American Journal of Hematology,Volume 0, Issue ja, -Not available-.
Source: American Journal of Hematology - Category: Hematology Authors: Anthony R.
Mato
MD MSCE
,
Lindsey E.
Roeker
MD
,
John N.
Allan
MD
,
John M.
Pagel
MD PhD
,
Danielle M.
Brander
MD
,
Brian T.
Hill
MD PhD
,
Bruce D.
Cheson
MD
,
Richard R.
Furman
MD
,
Nicole
Lamanna
MD
,
Constantine S.
Source Type: research
More News: Clinical Trials | Hematology